Stem Cell Therapy Market Analysis Report 2024-2029: iPSC Technology and Personalized Medicine Trends Drive Growth [Yahoo! Finance]
Cell Source, Inc. (CLCS)
NASDAQ:AMEX Investor Relations:
ir.cell-source.com/news/detail/11/cell-source-inc-announces-the-launch-of-its-new-investor-relations-website
Company Research
Source: Yahoo! Finance
Stem Cell Source, By Application, By End User, By Region Size and Trends Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. The global stem cell therapy market value in 2023 stood at US$9.65 billion, and is likely to reach US$23.07 billion by 2029. The global stem cell therapy market value is projected to grow at a CAGR of 15.97%, during the forecast period of 2024-2029. Stem cell therapy is a form of treatment that involves the use of stem cells to repair, replace, or regenerate damaged or diseased tissues in the body. Stem cells are unique because they have the ability to develop into different types of cells, such as muscle cells, nerve cells, or blood cells. This versatility makes them a valuable tool in regenerative medicine. While there are a growing number of potential therapies being tested in clinical trials there are only a few stem cell therapies that have so far been approved. The stem cell therapy market has experienced significant grow
Show less
Read more
Impact Snapshot
Event Time:
CLCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLCS alerts
High impacting Cell Source, Inc. news events
Weekly update
A roundup of the hottest topics
CLCS
News
- Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical Trial [Yahoo! Finance]Yahoo! Finance
- Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical TrialAccesswire
- India Dental Bone Graft Substitute Market Trends, Competition, Forecast and Opportunities, 2030 Featuring Key Vendors - Dentsply, Geistlich Pharma, NovaBone, Advanced Biotech Products, & Straumann [Yahoo! Finance]Yahoo! Finance